Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease
- Substances:Napazimone
Belgium- Participants:18–64 years · 65+ years
- Substances:Napazimone
- Sponsor:Pharming Technologies B.V.
Rare diseases
Investigational molecules
Locations
Back to Belgium1 642 clinical trials in Ath, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
BelgiumA study of JNJ-78278343 and docetaxel compared to docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer
BelgiumA study comparing AZD0486 after reduced chemotherapy versus standard chemotherapy in older or unfit patients with newly diagnosed large B-cell lymphoma
BelgiumA study to assess the safety of anumigilimab in adults with sickle cell disease
BelgiumTesting inotuzumab ozogamicin and blinatumomab with drug combination for children with relapsed precursor B-cell acute lymphoblastic leukemia
BelgiumA Study of SAB-142 to Slow the Progression of Type 1 Diabetes in Adults and Children Recently Diagnosed with the Disease
BelgiumStudy of Rilvegostomig or Pembrolizumab for First-line Treatment in Patients with PD-L1-high Metastatic Non-small Cell Lung Cancer
BelgiumLong-term safety and effectiveness study of atacicept in patients with IgA nephropathy (IgAN)
BelgiumStudy on the Long-Term Safety of Belimumab for Adults with Systemic Sclerosis-Related Lung Disease
BelgiumStudy on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)
BelgiumStudy on the Safety and Effectiveness of EIK1001 and Pembrolizumab for Patients with Advanced Melanoma
BelgiumStudy on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Clinical research in Ath addresses critical cardiovascular conditions, particularly focusing on cerebrovascular events. Investigations center on acute ischemic stroke and high-risk transient ischemic attack, conditions that represent significant causes of disability and mortality. These studies aim to evaluate novel therapeutic approaches designed to reduce the risk of recurrent ischemic events in patients who have experienced these serious cerebrovascular incidents.
The research underway seeks to establish safer and more effective treatment protocols for individuals at elevated risk of stroke, potentially improving long-term neurological outcomes and quality of life for affected patients.
Ath hosts clinical investigations in the field of oncology, with particular emphasis on gastrointestinal malignancies. Research efforts concentrate on locally advanced rectal cancer, examining treatment strategies tailored to specific patient populations. These trials explore different approaches to neoadjuvant therapy, which involves treatment administered before surgical intervention, aiming to optimize the balance between treatment effectiveness and patient safety.
These studies are particularly significant as they address the unique needs of older patients with rectal cancer, seeking to identify treatment regimens that maximize therapeutic benefit while minimizing adverse effects in this vulnerable population.
Tell us about your condition – we search every trial in Europe and connect you with the right site.